Eris Lifesciences Ltd.
ERIS Share PricePharmaceuticals & Drugs
₹1,566.5
16.1 (1%)
As on November 17, 2025
Exchange Scrips: BSE540596NSEERISISININE406M01024
Market Cap ₹ 21,317 Cr
P/E Ratio 60.64
Dividend Yield 0.47 %
Performance
Market performance
Open1,572.5
High1,572.5
Volumes46,611
Prev1,566.5
Low1,547.6
As on2025-11-17
Historical performance
1 Year High1,910
3 Year High1,910
5 Year High1,910
1 Year Low1,097.2
3 Year Low551.3
5 Year Low473.5
Fundamentals
Company Valuation
Market Cap (₹Cr)
21,317
Face Value (₹)
1
P/E Ratio
60.64
Dividend Yield
0.47 %
Investment Returns
1 Year
15.8%
3 Years
128.3%
5 Years
196.7%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,561.38 | Bullish |
| 10-DMA | 1,577.66 | Bearish |
| 20-DMA | 1,591.53 | Bearish |
| 50-DMA | 1,619.3 | Bearish |
| 100-DMA | 1,680.21 | Bearish |
| 200-DMA | 1,548.21 | Bullish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 59433 | 52220 | 50082 | 53309 | 46341 |
| Government | 1 | 1 | 1 | 1 | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 60.64.
- 3Y Stock Price CAGR of the stock is 32.2.
- The stock has a beta of 0.5.
- In the last financial year, the company had an EBITDA of ₹10356 Million.
- The company generated revenue of ₹28936 Million in the previous financial year.
Eris Lifesciences Ltd.
1566.516.1 (1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1157498.1
No. of Shares: 739 (Approx)
Performance:15.7%
P/L: ₹157498.1
Top Gainers
| Symbol | Change% |
|---|---|
| VLSFINANCE | 252.31(20%) |
| GROWW | 174.45(18%) |
| BASML | 29.03(16%) |
| ENERGYDEV | 22.18(16%) |
| MACPOWER | 979.2(15%) |
Peer Comparison
Get Your Portfolio Reviewed
